Alexza Pharmaceuticals files $150 million shelf registration

By E. Janene Geiss

Philadelphia, April 2 - Alexza Pharmaceuticals, Inc. filed a $150 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, debt securities, warrants and units. The securities may be structured as convertibles.

The Palo Alto, Calif., pharmaceutical company plans to use proceeds for research and development and general corporate purposes, including making investments.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.